INO
Inovio Pharmaceuticals Inc
Price:  
9.55 
USD
Volume:  
496,652.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO Relative Valuation

-1694.5%
Upside

As of 2024-03-02, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (152.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.55 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -1694.5%.

The range of the Relative Valuation is (133.83) - (173.32) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.5x - 25.3x 22.4x
Forward P/E multiples 17.5x - 24.0x 19.7x
Fair Price (133.83) - (173.32) (152.27)
Upside -1501.3% - -1914.9% -1694.5%
9.55 USD
Stock Price
(152.27) USD
Fair Price

INO Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -1.32
2024-02-29 -1.22
2024-02-28 -1.17
2024-02-27 -1.25
2024-02-26 -1.13
2024-02-23 -1.09
2024-02-22 -1.06
2024-02-21 -1.09
2024-02-20 -1.13
2024-02-16 -1.10
2024-02-15 -1.03
2024-02-14 -1.01
2024-02-13 -0.90
2024-02-12 -0.98
2024-02-09 -0.93
2024-02-08 -0.79
2024-02-07 -0.73
2024-02-06 -0.73
2024-02-05 -0.68
2024-02-02 -0.70
2024-02-01 -0.73
2024-01-31 -0.75
2024-01-30 -0.81
2024-01-29 -0.86
2024-01-26 -0.85
2024-01-25 -0.94
2024-01-24 -0.96
2024-01-23 -0.96
2024-01-22 -1.15
2024-01-19 -1.12
2024-01-18 -1.19
2024-01-17 -1.16
2024-01-16 -1.25
2024-01-12 -1.28
2024-01-11 -1.47
2024-01-10 -1.45
2024-01-09 -1.43
2024-01-08 -1.23
2024-01-05 -1.19
2024-01-04 -0.95
2024-01-03 -0.86
2024-01-02 -0.94
2023-12-29 -0.85
2023-12-28 -0.86
2023-12-27 -0.85
2023-12-26 -0.87
2023-12-22 -0.74
2023-12-21 -0.68
2023-12-20 -0.64
2023-12-19 -0.64